|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 977.90 USD | -2.56% |
|
-4.67% | -9.35% |
| 01:17am | Roche, Zealand Pharma Obesity Drug Hits Goal in Midstage Trial | DJ |
| 12:31am | Roche's obesity drug shows up to 10.7% weight loss in mid-stage trial | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 1,109.94 | 1,109.94 | 1,080.36 |
| Spread/Res. | -12.23% | -12.23% | -9.82% |
| Spread/Supp. | -2.91% | +8.38% | +19.88% |
| Support | 1,003.46 | 898.95 | 812.69 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- LLY Stock
- Charts Eli Lilly and Company
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition